This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
QuantalX Neuroscience
Visit WebsiteBreaking the boundaries in brain and neurological disease diagnosis the company is finding solutions for direct and real-time diagnosis of Dementia, Alzheimers, Stroke, silent cerebrovascular disease, and cerebral small vessels disease.
It is employing new, cutting-edge technologies with breakthrough scientific and technological R&D.
The company created the first non-invasive probe for direct brain network visualization.
Product:
Dephi MD
The First Objective, Patient-Independent System for Visualization of Brain Health. Delphi·MD offers physicians an ‘in office’ brain physiology and health scan that does not require patient participation or relay on cognitive testing. The Delphi Magnetic probe directly ‘pings’ specific brain networks producing an ‘ECG’ like signature of brain electrophysiological response that is robustly similar in healthy brain networks but changes significantly in pathological states.
Subsidiaries
Portfolio
- ProAxsis
- Glycotest
- Cetromed
- PDS Biotechnology
- Vortex Biosciences
- Wanda Health
- Q-Bot
- Sofant Technologies
- PointGrab
- SageTech Medical
- Dname-iT
- Oncocidia
- Ventive
- DeepTech Recycling
- G-Tech Medical
- FOx Biosystems
- EpiBone
- Cytovale
- Longevity Biotech
- QuantalX Neuroscience
- Insight Photonics
- Nanotech Industrial Solutions
- Martlet Capital